The Inflammation, Repair and Development Section’s seminar series continues by welcoming Dr Douglas Dyer, a Sir Henry Dale Fellow at the Wellcome centre for cell-matrix research at the University of Manchester. He has made very important contributions to our understanding of mechanisms underlying chemokine mediated leucocyte trafficking during inflammation. His lab is focused on using biochemistry, biophysics and in vivo biology approaches to study chemokines, the glycocalyx and inflammatory disease. He is specifically interested in understanding how chemokines enable leukocyte crossing of the adhesion-resistant endothelial glycocalyx barrier and how the glycocalyx barrier regulates leukocyte migration/endothelial permeability; processes that play a vital role in diverse inflammatory diseases and cancer.